baber/WOPTO huggingface dataset:
Patent FI-944672-A0 (FI)
Inventor: SALONEN JUKKA
IPC: A61K6/838
Filed: 1994-10-06
Abstract: PCT No. PCT/FI95/00539 Sec. 371 Date Apr. 2, 1997 Sec. 102(e) Date Apr. 2, 1997 PCT Filed Oct. 2, 1995 PCT Pub. No. WO96/10985 PCT Pub. Date Apr. 18, 1996A pharmaceutical preparation, including a glass phase which is bioactive silica containing glass in the form of a paste, suspension or solution mixed in a physiologically suitable liquid or bound to a physiologically suitable vehicle, and which preparation reduces the pulpal irritation or a tooth and/or strengthens the structure of a tooth. Bioactive silica containing glass may be a material which contains only Si-oxide or Si-hydroxide and which allows the formation and movement of Si-OH-groups. Preferably, the preparation also contains calcium and phosphate sources.
Patent FI-954333-A0 (FI)
Inventor: KOIVUNIEMI PEKKA
IPC: G06F12/0866
Filed: 1995-09-14
Abstract: In fault-tolerant systems it is known to write data into two separate disk drives. It is also known to duplex computers so that when one computer fails, the other computer can continue operating. In such a system, the active unit usually controls both disk drives. It is also known to cache in the main memory of the computer the most recently used areas in the disk drive, since it is likely that these areas (e.g. directories) must be read again soon. A problem occurs when using duplexed computers each of which is to be provided with a possibility of using the disk drive (14, 24) while the operation is expedited by caching in the main memories of the computers (10, 20). If one computer modifies the data in the disk drive, the other computer is not necessarily aware of this, but it uses the outdated data in its memory. According to the invention, the computer (10) desiring to control the disk drive (14) reserves it for itself. If the reservation is successful, a disk talk is performed. If the data in the disk drive (14) is changed, the other computer (20) is informed of this change and it erases from its memory the cached data corresponding to the changed data.
Patent FI-955403-A0 (FI)
Inventor: CHOI HOO-KYUN
IPC: A61K31/70
Filed: 1995-11-09
Abstract: There is disclosed a topical formulation containing glycols, glycerides, or their derivatives, an avermectin compound (active ingredient) and optionally a polymeric material which has been discovered to provide superior efficacy against endoparasites and ectoparasites when compared to conventional formulations and to maintain the concentration of the active compound in the milk of dairy animals below a safe concentration for human consumption. The formulation contains the avermectin active ingredient and at least 50 % of the glycol or glyceride or polymeric material.
Patent FI-991086-A0 (FI)
Inventor: SAARELMA HANNU
IPC: G03B19/00
Filed: 1999-05-11
Abstract: The invention relates to a camera system and to a display device for displaying images recorded by the camera system. The camera system comprises a camera ( 1 ) provided with an optics system ( 2 ) and a photosensitive image surface ( 3 ) disposed near the optics symmetrically relative to its optic axis, the image refracted by the optics being projected onto said image surface. The photosensitive image surface is a concave spherical surface whose center of curvature is at the focal point of the optics.
Patent AP-9801274-A0 (AP)
Title: Lactone derivatives of 17, beta.carboxy, carbothio and amide androstane derivatives.
Inventor: BIGGADIKE KEITH
IPC: A61K31/00
Filed: 1996-12-19
Abstract: Compounds of the androstane series are described having general formula (i)and solvates thereof, in which r1 represents o,s or nh; r2 individually represents oc(-o)c1-6 alkyl;r3 individually represents hydrogen, methyl (which may be in either the a or b configuration)or methylene; or r2 and r3 together represent (a)wherein r6 and r7 are the same or different and each represents hydrogen or c1-16 alkyl; r4 and r5 are the same or different and each represents hydrogen or halogen; and (b)represents a single or a double bond. Compounds of formula (i)and their solvates have use in medicine as anti-inflammatory or anti-inflammatory or anti-allergic agents.
Patent IL-72406-A0 (IL)
Title: Peritelescope
IPC: G02B23/08
Filed: 1984-07-13
Abstract: A peritelescope comprising elevation scanning apparatus (30) and azimuth scanning apparatus (32), the elevation scanning apparatus (30) and azimuth scanning apparatus (32) being operative and cooperative to provide a 360 degree field of view in elevation and a 360 degree field of view in azimuth.
Patent IL-73889-A0 (IL)
Title: Multistage combination preparation and its use for oral contraception
IPC: A61K31/57
Filed: 1984-12-21
Abstract: A multistage combination preparation is useful for oral contraception and comprises a surprisingly low amount of gestodene as the gestagen and comprises ethinylestradiol as the estrogen.
Patent IL-86377-A0 (IL)
Title: Polyfluorinated amino alcohols and their esters,their preparation and their use
IPC: C07C215/12
Filed: 1988-05-13
Abstract: The invention relates to new polyfluorinated compounds which are usable as anti-wear additives for lubricants. These compounds are of general formula:    <IMAGE>  (III)  in which RF is a perfluoroalkyl radical, R1 and R3 each denote a hydrogen atom or an alkyl, cycloalkyl or aryl radical, R2 and R4 each denote a hydrogen atom or an acyl residue, m equals 0 or 1 and X denotes a hydrogen atom or a 2-hydroxy-1-phenylethyl group. They are prepared by hydrogenation of amino alcohols of formula: RF-CF=CH-CH2-NH-CH2CH(R1)-OH followed, where appropriate, by a reaction with an epoxide and/or an esterification.
Patent IL-87628-A0 (IL)
Title: Stabilised human protein preparations and process for the production thereof
IPC: A61K38/00
Filed: 1988-08-31
Abstract: The preparations are well tolerated and stable on storage and contain a human protein, especially erythropoietin, physiologically tolerated buffers and, where appropriate, complexing agents, isotonicising agents, calcium chloride and other substances customary for injection purposes and, moreover, in the injection form 5 - 50 g/l urea, 1 - 50 g/l amino acid, 0.05 - 5 g/l non-ionic wetting agent, and are produced as described.
Patent IL-91054-A0 (IL)
IPC: G03F5/22
Filed: 1989-07-20
Abstract: The invention provides a device for offset and similar printing from a continuous tone original to produce a halftone image on a photosensitive layer comprising means for screening the information via a first array of parallely extending lines of effective minimum optical density and a second array of parallely extending lines of effective maximum optical density, the arrays being interposed to form a composite array of substantially parallel, spaced-apart, alternating lines of effective maximum and minimum optical density, the lines delimiting therebetween zones of effective graduated optical density, the gradient inside each zone progressively varying from low optical density adjacent lines of the first array to high optical density adjacent lines of the second array, the spacing of lines of the first array being between about 100 and 400 lines per inch and wherein the resulting thickness of each reproduced line on a resulting developed photosensitive layer, generated by screening the information via the array, continuously varies as a function of the density of each information point of the original.
Patent IL-92192-A0 (IL)
Title: Aqueous solutions especially for cleaning high strength steel
IPC: F01D25/00
Filed: 1989-11-02
Abstract: There are provided improved aqueous chemical cleaning compositions for removing organic and inorganic combustion residues from steel products, said compositions meeting the hydrogen embrittlement potential test criteria set forth in ANSI/ASTM F 519-77. These compositions are of particular utility in cleaning gas turbines in the motoring and running modes. The compositions comprise ethoxylated amines, ethylene diamine tetra acetic acid and demineralized water having a conductivity of or below 0.9 micro mhos. The composition has important application for the aviation and outer-space industries.
Patent IL-93866-A0 (IL)
Title: Use of purpuromycin for the treatment of vaginal infections and pharmaceutical dosage forms for said use
IPC: A61P1/16
Filed: 1990-03-23
Abstract: Use of the antibiotic purpuromycin for the topical treatment of infectious vaginitis and topical dosage forms containing said product. The antibiotic purpuromycin is simultaneously active against the main causative agents of infectious vaginitis i.e.: Candida vaginalis, Trichomonas vaginalis and Gardnerella vaginalis.
Patent IL-97222-A0 (IL)
Title: Method and reagent for determining specific nucleotide
IPC: C07H21/04
Filed: 1991-02-12
Abstract: Detection of variable nucleotide(s) is based on primer extension and incorporation of detectable nucleoside triphosphates. By selecting the detection step primers from the region immediately adjacent to the variable nucleotide, this variation can be detected after incorporation of as few as one nucleoside triphosphate. Labelled nucleoside triphosphates matching the variable nucleotide are added and the incorporation of a label into the detection step primer is measured. The selection of the detection step primer is important to the method according to this invention and is dependent on the nucleotide sequence of interest. The detection step primers are preferably selected so to span the region immediately toward the 3' end from the variable nucleotide to be detected. The method is useful in identifying specific point mutations and genetic variations.
Patent IL-99560-A0 (IL)
Title: Olefin polymer films or sheets
IPC: C08F297/08
Filed: 1991-09-25
Abstract: Disclosed are films or sheets comprising an olefin polymer composition which is comprised of   (a) from about 10 to 50 parts of a propylene homopolymer having an isotactic index greater than 80, or a copolymer of propylene with ethylene and/or an another alpha-olefin, containing over 80% propylene and having an isotactic index greater than 80; (b) from about 5 to 20 parts of a semi-crystalline copolymer fraction, which copolymer is insoluble in xylene at room or ambient temperature; and c) from about 40 to 80 parts of a copolymer fraction of ethylene with propylene and/or another alpha-olefin, and optionally with minor amounts of a diene, said copolymer fraction containing less than 40% ethylene and/or other alpha-olefin, being soluble in xylene at room temperature, and having an intrinsic viscosity from 1.5 to 4 dl/g.   Coextruded films or sheets and laminates wherein at least one layer is a film or sheet as described above, and films or sheets of blends of the olefin polymer composition and another olefin polymer are also disclosed.
Patent AU-PM399594-A0 (AU)
Title: Antigenic preparation for treatment or prevention of helicobacter infection
IPC: C08B37/00
Filed: 1994-02-21
Abstract: An antigenic preparation for use in the treatment or prevention of Helicobacter infection in a mammalian host, comprises the lipopolysaccharide (LPS) of Helicobacter bacteria, particularly the LPS of H. pylori or H. felis, or an immunogenic fragment thereof.
Patent FI-20035243-A0 (FI)
Inventor: ISO-SIPILAE JUHA
IPC: G06F40/20
Filed: 2003-12-19
Abstract: The electronic device (10) has a memory that stores language-configuration data including several languages packages and information on the languages belonging to each package. A language package is selected for use in a voice user interface used for controlling the device functions. Independent claims are also included for the following: (1) method for performing user-interface language configurations; and (2) computer program for performing user-interface language configurations.
Patent IL-100358-A0 (IL)
Title: Concentrate which contains a biocide and which is primarily solid under ambient conditions
IPC: C08J3/20
Filed: 1991-12-12
Abstract: PCT No. PCT/EP91/02378 Sec. 371 Date Jun. 22, 1993 Sec. 102(e) Date Jun. 22, 1993 PCT Filed Dec. 9, 1991 PCT Pub. No. WO92/10530 PCT Pub. Date Jun. 25, 1992.A microbiocide-containing concentrate for use in thermoplastic polymers as well as in plastisols, is disclosed. The concentrate is primarily solid at ambient conditions and comprises from 1-30 wt% of a microbiocide, a polymer plasticizer and up to 20 wt% of a thermoplastic resin. These concentrates are primarily useful as masterbatch compositions used for incorporation into polymers in order to protect said polymers from fungal or bacterial attack. Along these lines, the present document also discloses processes for incorporating these materials into a polymer or plastisol, and polymers or plastisols made by these processes.
Patent IL-100628-A0 (IL)
Title: Process for preparing aluminium nitride powder via controlled combustion nitridation
IPC: C01B21/072
Filed: 1992-01-10
Abstract: Rapidly heat powdered aluminum in the presence of a source of nitrogen at a temperature of 1873 to 2373 K. to produce aluminum nitride, then promptly quench the aluminum nitride product. The product has a surface area between 2 and 8 square meters per gram and an oxygen content of less than 1.2 weight percent.
Patent IL-106191-A0 (IL)
Title: Valve for back-flushing of milk cans in mechanical milking machines
IPC: F16K11/085
Filed: 1993-06-30
Abstract: PCT No. PCT/EP93/01273 Sec. 371 Date Sep. 1, 1994 Sec. 102(e) Date Sep. 1, 1994 PCT Filed May 21, 1993 PCT Pub. No. WO94/02000 PCT Pub. Date Feb. 3, 1994.A valve for the reverse-flow flushing of teat cups in milking machinery has a housing with an interior and a channel to the atmosphere. The housing has three connections, a first connection for connecting with the teat cups, a second connection for connecting with the milk line and a third connection for connecting with the reverse-flow flush line. A disk is mounted for rotation in the interior of the housing and has channels permitting communication through the interior of the housing between the first and second connections and blocking the third connection when the disk is in the milking position, permitting communication through the interior of the housing between the first and third connections and blocking the second connection when the disk in the reverse-flow position and permitting communication through the interior of the housing between the first and second connections while blocking the third connection and the channel when the disk is in the rinsing position.
Patent IL-109185-A0 (IL)
Title: Inhalation device
IPC: A61M15/00
Filed: 1994-03-31
Abstract: PCT No. PCT/GB94/00712 Sec. 371 Date Jan. 2, 1996 Sec. 102(e) Date Jan. 2, 1996 PCT Filed Mar. 31, 1994 PCT Pub. No. WO94/22515 PCT Pub. Date Oct. 13, 1994A medication inhalation device includes a housing having a through-going pathway connecting an air inlet with an air outlet, a medicament reservoir adapted to receive a compacted body of powdered medicament, and metering means for dispensing a predetermined dose of medicament from the reservoir into the through-going pathway, the metering means including means for abrading the compacted body; the device is provided with a shutter movable between a first position in which the compacted body is isolated from the through-going pathway and a second position in which the compacted body is in communication with the through-going pathway wuch that a dose of medicament can be dispensed from the reservoir into the through-going pathway.
Patent IL-114127-A0 (IL)
Title: Thrombin inhibiting compounds
IPC: A61K38/55
Filed: 1995-06-13
Abstract: Compounds of the formula and the salts thereof with physiologically tolerated acids and the stereoisomers thereof, in which the substituents have the meanings stated in the description, are described. Also disclosed are intermediates for their preparation. The compounds are suitable for controlling diseases.
Patent IL-128089-A0 (IL)
Title: Punching press devices for profiled bars and method
IPC: B21D28/28
Filed: 1999-01-18
Abstract: A method and devices are disclosed for punching one or more holes in extruded hollow profiled bars (50; 70; 270) where a back-up matrix (42; 150-550) must be inserted and located in precise alignment with the punching male punch (66; 90) die. Accordingly, the matrixes are mounted to portable mandrel rods (40; 140) provided with settable stop brackets (44; 146). The rods are placed in their exact operative punching position, and removed therefter for processing the next bar. The method further provides for simultaniously punching holes in more than one wall of the profiled bars.
Patent IL-132298-A0 (IL)
Title: Method and device for making a container provided with a label
IPC: B29C45/14
Filed: 1998-04-17
Abstract: The present invention relates to a method and to Apparatus for molding a receptacle fitted with a covering label. The technical field of the invention is that of molding a receptacle out of plastics material. In a method of molding a receptacle fitted with a covering label (1b) which is inserted into the mold (93) prior to injection, the label is shaped and at least two edges of the label are joined together, after which the shaped label is placed on a male portion (91) of the mold.
Patent IL-149280-A0 (IL)
Title: Methods, kits and compositions for using pyrrole derivatives
IPC: A61P25/18
Filed: 2002-04-22
Abstract: The present invention provides methods and kits for treating social anxiety disorder, using a compound which is 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone or 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-5-hydroxy-2-oxohexyl)-1-isoindolinone or a pharmaceutically acceptable salt, optical isomer or prodrug thereof.  The present invention also provides compositions comprising said compound or a pharmaceutically acceptable salt, optical isomer or prodrug thereof and an additional compound useful to treat the aforementioned conditions.
Patent IL-157590-A0 (IL)
Title: Carbamate compounds for use in preventing or treating bipolar disorder
IPC: A61P25/24
Filed: 2002-02-21
Abstract: This invention is directed to a method for preventing or treating bipolar disorder comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula (I):wherein phenyl is substituted at X with one to five halogen atoms selected from the group consisting of fluorine, chlorine, bromine and iodine; and, R1 and R2 are independently selected from the group consisting of hydrogen and C1-C4 alkyl; wherein C1-C4 alkyl is optionally substituted with phenyl (wherein phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 alkoxy, amino, nitro and cyano).
Patent IL-158081-A0 (IL)
Title: Stainless steel alloy and elongated strips formed thereof
IPC: C21D6/02
Filed: 2002-03-26
Abstract: A precipitation hardenable stainless steel having the following weight percent composition is disclosed.The balance of the alloy is essentially iron and the usual impurities. One or more rare earth metals or calcium may be included in the alloy for removing and/or stabilizing phosphorus and sulfur. The alloy provides a unique combination of strength, toughness, and ductility. In accordance with another aspect of the present invention, there is described a useful article such as an aircraft structural component or a golf club head that is formed, at least in part, from the aforesaid alloy. In accordance with a further aspect of the present invention, there is described an elongated strip formed from the aforesaid and a method of making such strip material.
Patent IL-165131-A0 (IL)
Title: System for transdermal administering of rotigotinebase
IPC: A61K9/70
Filed: 2004-11-10
Abstract: The invention relates to a polymer matrix suitable for the transdermal administration of rotigotine [(-)-5, 6, 7, 8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphtol], containing a matrix for the transdermal administration of rotigotine [(-)-5, 6, 7, 8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1 naphtol], containing a matrix polymer which is supersaturated with a rotigotine base. Said polymer matrix is characterised in that the part of the rotigotine which is not dissolved in the matrix polymer is dispersed in the matrix polymer as amorphous particles having a maximum mean diameter of 30 mum, and the matrix is free of solubilisers, crystallisation inhibitors and dispersants. The invention also relates to a flat device for the transdermal administration of rotigotine, containing the above-mentioned, preferably silicon-based polymer matrix which is supersaturated with rotigotine, and a rear layer which is impermeable to the active ingredient.
Patent IL-173710-A0 (IL)
Title: Apparatus for lifting pipelines
Filed: 2006-02-13
Abstract: Apparatus for the lifting of pipelines, includes a frame having two vertical side beams and a transverse top beam interposed between the vertical beams. Two concave and symmetrically disposed supporting members pivotally connect to the two vertical beams, respectively, and are configured to achieve a pipe supporting position without applying a radial inwardly directed force to the bottommost portion of the pipe when the frame is suitably lowered and the supporting members are suitably pivoted. A driving unit is disposed within, and fixedly attached to, each of the supporting members, for generating a linear downwardly directed force; a force transmitting element connected to a driving unit rod along which a corresponding driving unit housing is slidingly displaceable. A control unit independently controls each of the driving units; and at least one connector releasably connects the two supporting members to one another when the supporting members are in a pipe supporting position. The control unit is adapted to immobilize the force transmitting elements against a trench bed in a pre-lifting mode when a first force is generated by the driving units, and to lift each of the driving unit housings together with the corresponding supporting member with respect to the corresponding force transmitting element in a lifting mode when a suitable second force greater than the first force is generated by each of the driving units.
Patent IL-178918-A0 (IL)
Title: Process for producing pentacyclic taxane
IPC: C07D493/04
Filed: 2006-10-29
Abstract: Taxan derivatives are produced efficiently and inexpensively, which are useful as oral-administrable antitumor compounds.  A compound of formula (1) (wherein R 1  is an alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, an aryl group or a heterocyclic group; R 2  is a hydroxyl group optionally having a protective group) is processed with an alkali metal permanganate to produce a compound of formula (2), which may be a starting material for oral-administrable antitumor compounds.
Patent IL-209509-A0 (IL)
Title: Preimplantation factor peptide
IPC: G01N33/68
Filed: 2010-11-22
Abstract: The present invention relates to assay methods used for detecting the presence of PIF, and to PIF peptides identified using this assay. In particular, the present invention relates to flow cytometry assays for detecting PIF. It is based, at least in part, on the observation that flow cytometry using fluorescently labeled anti-lymphocyte and anti-platelet antibodies demonstrated an increase in rosette formation in the presence of PIF. It is further based on the observation that flow cytometry demonstrated that monoclonal antibody binding to CD2 decreased in the presence of PIF. The present invention further relates to PIF peptides which, when added to Jurkat cell cultures, have been observed to either (i) decrease binding of anti-CD2 antibody to Jurkat cells; (ii) increase expression of CD2 in Jurkat cells; or (iii) decrease Jurkat cell viability. In additional embodiments, the present invention provides for ELISA assays which detect PIF by determining the effect of a test sample on the binding of anti-CD2 antibody to a CD2 substrate.